NL8703107A
(nl)
*
|
1987-12-22 |
1989-07-17 |
Nederlanden Staat |
Polypeptiden en derivaten daarvan, alsmede de toepassing daarvan in farmaceutische en diagnostische preparaten.
|
CA1338778C
(en)
*
|
1988-06-15 |
1996-12-10 |
Richard A. Young |
Stress proteins and uses therefor
|
EP0370581A1
(en)
*
|
1988-11-25 |
1990-05-30 |
Akzo N.V. |
Anti-hCG antibodies
|
US5114844A
(en)
*
|
1989-03-14 |
1992-05-19 |
Yeda Research And Development Co., Ltd. |
Diagnosis and treatment of insulin dependent diabetes mellitus
|
FR2645878B1
(fr)
*
|
1989-04-17 |
1994-02-25 |
Institut Nal Sante Recherc Medic |
Sequences nucleotidiques d'actinomycetales, applications a la synthese ou a la detection d'acides nucleiques, produits d'expression de ces sequences et application en tant que compositions immunogenes
|
SE9001105D0
(sv)
*
|
1990-03-27 |
1990-03-27 |
Astra Ab |
New methods foer diagnosis of tuberculosis
|
US5776693A
(en)
*
|
1990-06-08 |
1998-07-07 |
Institut Pasteur |
Specific detection of the mycobacterium tuberculosis
|
GB9111291D0
(en)
*
|
1991-05-24 |
1991-07-17 |
Medical Res Council |
Diagnostic peptides
|
FR2694754B1
(fr)
*
|
1992-08-12 |
1994-09-16 |
Bio Merieux |
Fragments d'ADN de mycobactéries, amorces d'amplification, sondes d'hybridation, réactifs et procédé de détection de détection de mycobactéries.
|
DK0700445T3
(da)
|
1993-06-04 |
2002-05-13 |
Whitehead Biomedical Inst |
Stressproteiner og anvendelser deraf
|
US5955077A
(en)
*
|
1993-07-02 |
1999-09-21 |
Statens Seruminstitut |
Tuberculosis vaccine
|
US6991797B2
(en)
*
|
1993-07-02 |
2006-01-31 |
Statens Serum Institut |
M. tuberculosis antigens
|
US6752993B1
(en)
|
1993-11-23 |
2004-06-22 |
The Regents Of The University Of California |
Abundant extracellular product vaccines and methods for their production and use
|
JPH09505588A
(ja)
|
1993-11-23 |
1997-06-03 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
多くの細胞外生成物及びそれらの製造法並びに使用
|
US7300660B2
(en)
*
|
1993-11-23 |
2007-11-27 |
The Regents Of The University Of California |
Abundant extracellular products and methods for their production and use
|
ATE260295T1
(de)
*
|
1994-03-21 |
2004-03-15 |
Univ Utrecht |
Peptidfragmente von mikrobiellen stressproteinen und daraus hergestellte pharmazeutische zusammensetzungen für die behandlung und vorbeugung von entzündungserkrankungen
|
US5874405A
(en)
*
|
1994-12-16 |
1999-02-23 |
Birnbaum; Gary |
Heat shock protein peptides that share sequences with cyclic nucleotide phosphodiesterase and methods for modulating autoimmune central nervous system disease
|
US6592877B1
(en)
*
|
1995-09-01 |
2003-07-15 |
Corixa Corporation |
Compounds and methods for immunotherapy and diagnosis of tuberculosis
|
US6338852B1
(en)
|
1995-09-01 |
2002-01-15 |
Corixa Corporation |
Compounds and methods for diagnosis of tuberculosis
|
US6290969B1
(en)
*
|
1995-09-01 |
2001-09-18 |
Corixa Corporation |
Compounds and methods for immunotherapy and diagnosis of tuberculosis
|
US6458366B1
(en)
*
|
1995-09-01 |
2002-10-01 |
Corixa Corporation |
Compounds and methods for diagnosis of tuberculosis
|
US6013660A
(en)
*
|
1996-10-02 |
2000-01-11 |
The Regents Of The University Of California |
Externally targeted prophylactic and chemotherapeutic method and agents
|
US7157089B1
(en)
|
1996-11-26 |
2007-01-02 |
Stressgen Biotechnologies Corporation |
Immune responses using compositions containing stress proteins
|
US6982085B2
(en)
*
|
1997-04-02 |
2006-01-03 |
Statens Serum Institut |
TB diagnostic based on antigens from M. tuberculosis
|
US7037510B2
(en)
|
1997-04-18 |
2006-05-02 |
Statens Serum Institut |
Hybrids of M. tuberculosis antigens
|
US6555653B2
(en)
|
1997-05-20 |
2003-04-29 |
Corixa Corporation |
Compounds for diagnosis of tuberculosis and methods for their use
|
US6613881B1
(en)
|
1997-05-20 |
2003-09-02 |
Corixa Corporation |
Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use
|
CN100489105C
(zh)
|
1997-08-05 |
2009-05-20 |
恩温塔生物制药学公司 |
包含hpv抗原和应激蛋白或者其表达载体的组合物激发的抗hpv抗原免疫应答
|
US20040013685A1
(en)
*
|
1997-11-10 |
2004-01-22 |
Peter Andersen |
Nucleic acid fragments and polypeptide fragments derived from M. tuberculosis
|
US6497880B1
(en)
|
1998-12-08 |
2002-12-24 |
Stressgen Biotechnologies Corporation |
Heat shock genes and proteins from Neisseria meningitidis, Candida glabrata and Aspergillus fumigatus
|
US6465633B1
(en)
|
1998-12-24 |
2002-10-15 |
Corixa Corporation |
Compositions and methods of their use in the treatment, prevention and diagnosis of tuberculosis
|
US8143386B2
(en)
*
|
1999-04-07 |
2012-03-27 |
Corixa Corporation |
Fusion proteins of mycobacterium tuberculosis antigens and their uses
|
AU5926700A
(en)
|
1999-07-08 |
2001-01-30 |
Stressgen Biotechnologies Corporation |
Induction of a th1-like response in vitro
|
WO2001016174A2
(en)
*
|
1999-08-30 |
2001-03-08 |
Rolf Kiessling |
Induction of cytotoxic t lymphocyte response by hla class ia restricted epitopes of mycobacterial heat shock protein 65
|
US7592304B2
(en)
|
1999-10-01 |
2009-09-22 |
Dmi Life Sciences, Inc. |
Metal-binding compounds and uses therefor
|
US7632803B2
(en)
*
|
1999-10-01 |
2009-12-15 |
Dmi Life Sciences, Inc. |
Metal-binding compounds and uses therefor
|
WO2001024820A1
(en)
*
|
1999-10-07 |
2001-04-12 |
Corixa Corporation |
Fusion proteins of mycobacterium tuberculosis
|
AU1814101A
(en)
|
2000-01-14 |
2001-07-24 |
Massachusetts Institute Of Technology |
In vivo CTL elicitation by heat shock protein fusion proteins maps to a discrete ATP binding domain and is CD4+ cell-independent
|
AU2001241738A1
(en)
*
|
2000-02-25 |
2001-09-03 |
Corixa Corporation |
Compounds and methods for diagnosis and immunotherapy of tuberculosis
|
SI1542732T1
(sl)
*
|
2000-06-20 |
2010-01-29 |
Corixa Corp Csc The United Sta |
Fuzijski proteini Mycobacterium tuberculosis
|
IL153474A0
(en)
|
2000-06-26 |
2003-07-06 |
Stressgen Biotechnologies Corp |
Human papilloma virus treatment
|
WO2002004018A2
(en)
*
|
2000-07-10 |
2002-01-17 |
Colorado State University Research Foundation |
Mid-life vaccine and methods for boosting anti-mycobacterial immunity
|
WO2002048175A2
(en)
*
|
2000-12-13 |
2002-06-20 |
Argonex Pharmaceuticals |
Mhc class i associated peptides for prevention and treatment of tuberculosis
|
MXPA03006971A
(es)
|
2001-02-05 |
2004-05-05 |
Stressgen Biotechnologies Corp |
Tratamiento del virus de hepatitis b.
|
US7026465B2
(en)
*
|
2002-02-15 |
2006-04-11 |
Corixa Corporation |
Fusion proteins of Mycobacterium tuberculosis
|
WO2004045539A2
(en)
*
|
2002-11-15 |
2004-06-03 |
Regents Of The University Of California |
Anti-microbial agents derived from methionine sulfoximine analogues
|
PL239045B1
(pl)
*
|
2018-01-09 |
2021-11-02 |
Inst Immunologii I Terapii Doswiadczalnej Polskiej Akademii Nauk |
Epitop specyficzny dla zakaźnych Streptococcus agalactiae oraz sposób wykrywania zakażenia pacjenta szczepem Streptococcus agalactiae
|